Dehydroadynerigenin glucosyldigitaloside

Details

Top
Internal ID 92a0eef6-7c6d-4538-82fd-6f64e6eb57d7
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > O-glycosyl compounds
IUPAC Name 3-[(1S,3R,7R,10R,11S,14S,16R)-14-[(2R,3R,4R,5S,6R)-3-hydroxy-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-5-en-6-yl]-2H-furan-5-one
SMILES (Canonical) CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC45C3CCC6(C4(O5)CC=C6C7=CC(=O)OC7)C)C)O)OC)OC8C(C(C(C(O8)CO)O)O)O
SMILES (Isomeric) C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@]45[C@@H]3CC[C@]6([C@]4(O5)CC=C6C7=CC(=O)OC7)C)C)O)OC)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O
InChI InChI=1S/C36H52O13/c1-17-29(48-31-27(41)26(40)25(39)22(15-37)47-31)30(43-4)28(42)32(45-17)46-20-6-9-33(2)19(14-20)5-11-35-23(33)8-10-34(3)21(7-12-36(34,35)49-35)18-13-24(38)44-16-18/h7,13,17,19-20,22-23,25-32,37,39-42H,5-6,8-12,14-16H2,1-4H3/t17-,19-,20+,22-,23-,25-,26+,27-,28-,29+,30-,31+,32+,33+,34-,35+,36-/m1/s1
InChI Key ULJZNLQMTRZTJF-RCQNOOMASA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C36H52O13
Molecular Weight 692.80 g/mol
Exact Mass 692.34079171 g/mol
Topological Polar Surface Area (TPSA) 186.00 Ų
XlogP 0.40
Atomic LogP (AlogP) 1.02
H-Bond Acceptor 13
H-Bond Donor 5
Rotatable Bonds 7

Synonyms

Top
144223-70-1
AKOS040761588
8,14-Epoxy-3beta-[(6-deoxy-3-O-methyl-4-O-beta-D-glucopyranosyl-beta-D-galactopyranosyl)oxy]-5beta-carda-16,20(22)-dienolide

2D Structure

Top
2D Structure of Dehydroadynerigenin glucosyldigitaloside

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7913 79.13%
Caco-2 - 0.8721 87.21%
Blood Brain Barrier - 0.7500 75.00%
Human oral bioavailability - 0.7714 77.14%
Subcellular localzation Mitochondria 0.7600 76.00%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8505 85.05%
OATP1B3 inhibitior + 0.9497 94.97%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior + 0.6446 64.46%
P-glycoprotein inhibitior + 0.7333 73.33%
P-glycoprotein substrate + 0.6095 60.95%
CYP3A4 substrate + 0.7302 73.02%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8875 88.75%
CYP3A4 inhibition - 0.9188 91.88%
CYP2C9 inhibition - 0.8145 81.45%
CYP2C19 inhibition - 0.8323 83.23%
CYP2D6 inhibition - 0.9291 92.91%
CYP1A2 inhibition - 0.8522 85.22%
CYP2C8 inhibition + 0.6086 60.86%
CYP inhibitory promiscuity - 0.8866 88.66%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6355 63.55%
Eye corrosion - 0.9865 98.65%
Eye irritation - 0.9248 92.48%
Skin irritation - 0.6591 65.91%
Skin corrosion - 0.9371 93.71%
Ames mutagenesis - 0.6524 65.24%
Human Ether-a-go-go-Related Gene inhibition + 0.6891 68.91%
Micronuclear - 0.6900 69.00%
Hepatotoxicity - 0.6000 60.00%
skin sensitisation - 0.8863 88.63%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity + 0.6000 60.00%
Nephrotoxicity - 0.6232 62.32%
Acute Oral Toxicity (c) I 0.6868 68.68%
Estrogen receptor binding + 0.7467 74.67%
Androgen receptor binding + 0.7559 75.59%
Thyroid receptor binding - 0.6244 62.44%
Glucocorticoid receptor binding + 0.6667 66.67%
Aromatase binding + 0.7056 70.56%
PPAR gamma + 0.6835 68.35%
Honey bee toxicity - 0.6110 61.10%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5434 54.34%
Fish aquatic toxicity + 0.9428 94.28%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.24% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 95.10% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.33% 97.09%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.38% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 92.54% 100.00%
CHEMBL226 P30542 Adenosine A1 receptor 92.24% 95.93%
CHEMBL2581 P07339 Cathepsin D 90.59% 98.95%
CHEMBL1937 Q92769 Histone deacetylase 2 89.91% 94.75%
CHEMBL1293249 Q13887 Kruppel-like factor 5 88.23% 86.33%
CHEMBL216 P11229 Muscarinic acetylcholine receptor M1 87.99% 94.23%
CHEMBL5608 Q16288 NT-3 growth factor receptor 87.90% 95.89%
CHEMBL218 P21554 Cannabinoid CB1 receptor 87.75% 96.61%
CHEMBL1806 P11388 DNA topoisomerase II alpha 87.52% 89.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 86.18% 94.45%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 85.86% 94.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.79% 95.56%
CHEMBL5255 O00206 Toll-like receptor 4 82.93% 92.50%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 82.04% 96.00%
CHEMBL241 Q14432 Phosphodiesterase 3A 80.44% 92.94%
CHEMBL1871 P10275 Androgen Receptor 80.41% 96.43%

Cross-Links

Top
PubChem 92023995
NPASS NPC257466
LOTUS LTS0000984
wikiData Q105275178